Fetal Bovine Serum Is Essential for Maintaining Viability of Porcine Blastocysts During Extended In Vitro Culture: A Comparative Study With Defined Supplements
Reproduction in Domestic Animals · 2026-03 · 61 (3)
DOI: 10.1111/rda.70195 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Reproduction in Domestic Animals, online erschienen am 09.03.2026. Verfasst von Seongju Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Theriogenology and Reproductive Biotechnology, College of Veterinary Medicine, Jeonbuk National University, Iksan, Republic of Korea. Hauptthemen laut MEDLINE: Embryo Culture Techniques, Blastocyst, Culture Media, Serum. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chungnam National University.
Abstract (Originalsprache)
Extended in vitro culture (EIVC) of porcine embryos beyond Day 7 is critical for understanding peri‐implantation development but remains technically challenging due to the rapid degeneration of blastocysts. While defined serum‐free supplements, such as B27 and growth factor cocktails (FGF2, LIF, IGF1; FLI), have successfully supported EIVC in bovine and murine models, their efficacy in porcine embryos has not been systematically evaluated against fetal bovine serum (FBS). This study investigated the effects of these supplements on the long‐term viability and molecular integrity of porcine blastocysts. Porcine blastocysts produced in vitro were cultured from Day 7 to Day 11 in Porcine Zygote Medium (PZM) supplemented with either 10% FBS, FLI cocktail, B27 or no supplement (Control). Contrary to findings in other species, supplementation with FLI or B27 failed to support porcine blastocyst survival, resulting in complete degeneration by Day 11, similar to the control group. In contrast, FBS supplementation significantly extended blastocyst viability and maintained structural integrity up to Day 11. Although blastocyst expansion plateaued after Day 9, the FBS group retained a significantly higher total cell number and preserved the expression of pluripotency ( OCT4 , SOX2 ) and lineage ( CDX2 , GATA6 ) markers compared to other groups. Furthermore, FBS significantly suppressed apoptosis, as evidenced by a lower BAX/BCL2 ratio. These findings demonstrate a distinct species‐specific requirement for porcine EIVC; defined supplements effective in other mammals are insufficient for pigs, suggesting that while FBS is essential for preventing rapid degeneration and maintaining cellular viability, further optimisation is required to fully support extended developmental progression comparable to in vivo peri‐implantation elongation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Theriogenology and Reproductive Biotechnology, College of Veterinary Medicine, Jeonbuk National University, Iksan, Republic of Korea.
- Laboratory of Theriogenology, College of Veterinary Medicine, Chungnam National University, Daejeon, Republic of Korea.
ORCID-Profile: Seongju Lee, Il-Jeoung Yu, Yubyeol Jeon
Förderung
- Chungnam National University
Zitieren
APA
Lee, S., Yu, I. J., & Jeon, Y. (2026). Fetal Bovine Serum Is Essential for Maintaining Viability of Porcine Blastocysts During Extended In Vitro Culture: A Comparative Study With Defined Supplements. Reproduction in Domestic Animals, 61(3). https://doi.org/10.1111/rda.70195
Vancouver
Lee S, Yu IJ, Jeon Y. Fetal Bovine Serum Is Essential for Maintaining Viability of Porcine Blastocysts During Extended In Vitro Culture: A Comparative Study With Defined Supplements. Reproduction in Domestic Animals. 2026;61(3). doi:10.1111/rda.70195
BibTeX
@article{Lee2026,
author = {Lee, Seongju and Yu, Il-Jeoung and Jeon, Yubyeol},
title = {Fetal Bovine Serum Is Essential for Maintaining Viability of Porcine Blastocysts During Extended In Vitro Culture: A Comparative Study With Defined Supplements},
journal = {Reproduction in Domestic Animals},
year = {2026},
volume = {61},
number = {3},
doi = {10.1111/rda.70195}
}
EUVIMED